Potter M, Moore M
Clin Exp Immunol. 1981; 44(2):332-41.
PMID: 7307338
PMC: 1537332.
Schacter B, Kleinhenz M, Edmonds K, Ellner J
Clin Exp Immunol. 1981; 46(3):640-8.
PMID: 7039896
PMC: 1536302.
Ellner J, Olds G, Lee C, Kleinhenz M, Edmonds K
J Clin Invest. 1982; 70(2):369-78.
PMID: 6980229
PMC: 371245.
DOI: 10.1172/jci110626.
Platsoucas C, GOOD R
Proc Natl Acad Sci U S A. 1981; 78(7):4500-4.
PMID: 6974866
PMC: 319819.
DOI: 10.1073/pnas.78.7.4500.
Matera L, Potter M, Moore M
Immunology. 1981; 44(4):765-72.
PMID: 6947964
PMC: 1554994.
Depression of the generation of cell-mediated cytotoxicity after surgery.
Miyazaki S, Akiyoshi T, Arinaga S, Koba F, Tsuji H
Jpn J Surg. 1983; 13(3):191-5.
PMID: 6632392
DOI: 10.1007/BF02469475.
Human anti-lymphoma responses generated in vitro and in vivo following sensitization with allogeneic leukocytes.
Zarling J, Kay N, Grant B, Yasukawa M, Bach F
Cancer Immunol Immunother. 1983; 15(3):237-9.
PMID: 6604571
PMC: 11039179.
DOI: 10.1007/BF00199171.
Lysis of fresh human solid tumor cells by autologous lymphocytes activated in vitro by allosensitization.
Mazumder A, Grimm E, Rosenberg S
Cancer Immunol Immunother. 1983; 15(1):1-10.
PMID: 6603260
PMC: 11039249.
DOI: 10.1007/BF00199454.
Clonal analysis of cytotoxic T cell response against human melanoma.
Mukherji B, Macalister T
J Exp Med. 1983; 158(1):240-5.
PMID: 6602860
PMC: 2187080.
DOI: 10.1084/jem.158.1.240.
Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.
Grimm E, Ramsey K, Mazumder A, Wilson D, Djeu J, Rosenberg S
J Exp Med. 1983; 157(3):884-97.
PMID: 6601174
PMC: 2186968.
DOI: 10.1084/jem.157.3.884.
Two distinct phenotypes of HLA-DR-specific cytotoxic T-cell lines.
Flomenberg N, Duffy E, Naito K, DuPont B
Immunogenetics. 1983; 17(3):317-24.
PMID: 6601055
DOI: 10.1007/BF00364415.
The role of allogeneic cells in the stimulation of cell-mediated cytotoxicity to leukaemia cells. A family study.
Taylor G, Bradley B
Cancer Immunol Immunother. 1983; 15(1):39-46.
PMID: 6553506
PMC: 11039205.
DOI: 10.1007/BF00199460.
Cells that mediate NK like cytotoxicity are present in the human delayed type hypersensitivity response.
Tartof D, Yung C, Curran J, Livingston C, Thalji Z
Clin Exp Immunol. 1984; 58(2):462-9.
PMID: 6499283
PMC: 1577054.
In vitro stimulation of cell-mediated cytotoxicity by acute leukaemias.
Taylor G
Br J Cancer. 1981; 43(2):157-68.
PMID: 6451236
PMC: 2010526.
DOI: 10.1038/bjc.1981.24.
The skin test antigen stimulated killer (STAK) cell mediating NK like CMC is OKM1 positive and OKT3 negative.
Tartof D, Curran J, Levitt D, Loken M
Clin Exp Immunol. 1983; 54(2):561-6.
PMID: 6360439
PMC: 1535880.
Activated lymphocyte killer cells derived from melanoma tissue or peripheral blood.
Burns G, Good M, Riglar C, Bartlett P, Crapper R, Mackay I
Clin Exp Immunol. 1984; 57(2):487-94.
PMID: 6331928
PMC: 1536130.
Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.
Klein E, Masucci M
Springer Semin Immunopathol. 1982; 5(1):63-73.
PMID: 6314570
DOI: 10.1007/BF00201957.
X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency.
Sullivan J, Byron K, Brewster F, Baker S, Ochs H
J Clin Invest. 1983; 71(6):1765-78.
PMID: 6306053
PMC: 370382.
DOI: 10.1172/jci110932.
Depression of the generation of cell-mediated cytotoxicity by suppressor cells after surgery.
Miyazaki S, Akiyoshi T, Arinaga S, Koba F, Wada T, Tsuji H
Clin Exp Immunol. 1983; 54(2):573-9.
PMID: 6228356
PMC: 1535868.
"Anomalous" Thy-1+ killer cells in allogeneic and F1-anti-parental mixed leukocyte culture. Relation to natural killer cells and allospecific cytotoxic T lymphocytes.
Karre K, Seeley J, Eriksson E, Burton R, Kiessling R
J Exp Med. 1983; 157(2):385-403.
PMID: 6185610
PMC: 2186922.
DOI: 10.1084/jem.157.2.385.
